TABLE 1.
Correlation between lncSNHG3 expression and clinicopathological characteristics of 70 patients with bladder cancer
Characteristics | Group | Total | lncSNHG3 expression | P value | |
---|---|---|---|---|---|
High | Low | ||||
Gender | Male | 51 | 37 | 14 | 0.115 |
Female | 19 | 10 | 9 | ||
Age (years) | <60 | 29 | 11 | 4 | 0.587 |
≥60 | 41 | 36 | 19 | ||
Tumour size (cm) | <3 cm | 37 | 20 | 17 | 0.014* |
≥3 cm | 33 | 27 | 6 | ||
Histological grade | L | 31 | 23 | 8 | 0.263 |
H | 39 | 24 | 15 | ||
T stage | 1/2 | 45 | 30 | 15 | 0.909 |
3/4 | 25 | 17 | 8 | ||
Lymph nodes metastasis | Present | 8 | 6 | 2 | 0.615 |
Absent | 62 | 41 | 21 | ||
Postoperative metastasis | Metastasis | 26 | 22 | 4 | 0.017* |
Non‐metastasis | 44 | 25 | 19 |
P < 0.05 or **P < 0.01 was considered significant (Chi‐square test between 2 groups).